drugset / Trial / NCT02335359
Tranexamic Acid in Major Vascular Surgery
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine whether tranexamic acid is effective in reducing intraoperative blood loss and necessity for haemotransfusion in patients undergoing open abdominal aortic aneurysm repair
Timeline
- Start
- 2015-03-04
- Primary completion
- 2017-10-30
- Completion
- 2018-10-30
Outcome
Missed primary endpoint
paper Median (inter-quartile range) intraoperative blood loss was 400 (300-1050) ml in the tranexamic acid group vs 500 (360-1000) ml in the placebo group (P=0.44). PMID 31607387 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 250 mg | Intravenous |
Indications
No indication recorded.